The current advances and future perspectives of lateral flow immunoassay for infectious diseases

Abstract

Although much progresses have been made, preventing and curing infectious diseases have proven increasingly unable to keep pace with the spread of these pandemics. Therefore, there is fueled demanding for accurate, speed, affordable, and convenient diagnostic assays. Recent years, tremendous efforts to develop the point-of-care (POC) testing have provided plenty of solutions to meet above requirements, their application will be especially useful in resource-limited countries and areas. In this perspective, we discuss the recent advances and emerging potentials of POC diagnostic, mainly focusing on lateral flow immunoassay (LFA), to overview how this powerful and portable platform facilitates to fighting diverse pathogens in our real world. We hope this review can be helpful for interested infectious disease researchers and physicians.